Philadelphia, PA, United States of America

Paul Nugent

This inventor holds 1 USPTO granted patent. Top assignee: Thomas Jefferson University. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Nugent. Retrieved from https://idiyas.com/inventor/paul-nugent-6gjtcrcd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Paul Nugent

Introduction

Paul Nugent is an accomplished inventor based in Philadelphia, PA. He has made significant contributions to the field of biotechnology, particularly through his work on antisense oligonucleotides. His innovative approach aims to inhibit the expression of both mutated and wild-type genes, showcasing his commitment to advancing medical science.

Latest Patents

Paul Nugent holds one patent that focuses on antisense oligonucleotides designed to inhibit gene expression. This patent represents a crucial step in the development of targeted therapies for various genetic disorders.

Career Highlights

Nugent is affiliated with Thomas Jefferson University, where he conducts research and collaborates with other experts in the field. His work at the university has positioned him as a key figure in the exploration of genetic therapies.

Collaborations

Some of his notable coworkers include Darwin J. Prockop and Alain Colige. Their collaborative efforts contribute to the advancement of research in biotechnology and genetic engineering.

Conclusion

Paul Nugent's innovative work in the field of biotechnology exemplifies the impact of targeted therapies on modern medicine. His contributions continue to inspire future research and development in genetic treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…